Biotech Bounce BackNovavax is showing promising setup characteristics, with a daily gap forming at the ~$7.00 level and a breakout above ~$9.75 poised to target resistance at ~$10.30. This trade offers a strong risk‑to‑reward profile, with a stop‑loss around $6.13.
Fundamentally, Novavax remains relevant in the biote
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.811 EUR
−181.12 M EUR
658.95 M EUR
148.32 M
About Novavax, Inc.
Sector
Industry
CEO
John C.s Jacobs
Website
Headquarters
Gaithersburg
Founded
1987
ISIN
US6700024010
FIGI
BBG01Q6C2B10
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Related stocks
Novavax Stock Chart Fibonacci Analysis 090625Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 7.3/61.80%
Chart time frame:C
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress:A
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
E)
LONG NVAX"Novavax is the dark horse of the pharma race – while the market watches Pfizer and Moderna, NVAX is quietly strengthening its position with an improved protein-based vaccine. The approval of their combined COVID and flu shot might be just the beginning. And here’s the kicker – in every bull run, sp
NVAX Update (Responding to Some Requests)I wrote this in response to a comment on a previous update, but I'm publishing this here because some others have requested an update as well.
Remember: I'm just some dude on the internet and I'm not a financial advisor. So please keep that in mind.
For me, personally, NVAX is a patience game. I
NVAX Potential Breakout!Potential Breakout in the next week for NVAX. Would not be surprised to see a move to around $10.60 in the next few days. If it can break the bigger wedge, a potential big upside to around $14-$15 range.
Besides this short term idea, the stock has even greater upside from a TA point of view if you
$NVAX - GAP FILL & BREAK OF TRANEDLINE NASDAQ:NVAX gaining momentum again along with other pharma's. Its interestingly filling the gap anf has i high possibility of retesting the high of the channel. I have a starter position and will be adding if it decides to test the trend line. A daily close below the trendline is my stop. Playing e
Shot At Vaccinating Gains!Novavax (NVAX) is demonstrating strong bullish momentum, with a gap forming around the $8.75 level. A breakout above the $14.60 monthly resistance would confirm continued strength, positioning the stock to target $23.71. This trade offers an excellent risk-to-reward ratio, with downside risk managed
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
NVAX6156110
Novavax, Inc. 4.625% 01-SEP-2031Yield to maturity
—
Maturity date
Sep 1, 2031
NVAX5729297
Novavax, Inc. 5.0% 15-DEC-2027Yield to maturity
—
Maturity date
Dec 15, 2027
See all NVAX bonds
Curated watchlists where NVAX is featured.
Frequently Asked Questions
The current price of NVAX is 5.545 EUR — it has increased by 0.67% in the past 24 hours. Watch Novavax, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange Novavax, Inc. stocks are traded under the ticker NVAX.
NVAX stock has fallen by −11.82% compared to the previous week, the month change is a −19.05% fall, over the last year Novavax, Inc. has showed a −27.40% decrease.
We've gathered analysts' opinions on Novavax, Inc. future price: according to them, NVAX price has a max estimate of 21.57 EUR and a min estimate of 5.18 EUR. Watch NVAX chart and read a more detailed Novavax, Inc. stock forecast: see what analysts think of Novavax, Inc. and suggest that you do with its stocks.
NVAX reached its all-time high on Oct 4, 2024 with the price of 13.350 EUR, and its all-time low was 4.706 EUR and was reached on Apr 10, 2025. View more price dynamics on NVAX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NVAX stock is 2.92% volatile and has beta coefficient of 1.40. Track Novavax, Inc. stock price on the chart and check out the list of the most volatile stocks — is Novavax, Inc. there?
Today Novavax, Inc. has the market capitalization of 893.05 M, it has decreased by −5.65% over the last week.
Yes, you can track Novavax, Inc. financials in yearly and quarterly reports right on TradingView.
Novavax, Inc. is going to release the next earnings report on Mar 4, 2026. Keep track of upcoming events with our Earnings Calendar.
NVAX earnings for the last quarter are −1.07 EUR per share, whereas the estimation was −1.02 EUR resulting in a −4.49% surprise. The estimated earnings for the next quarter are −0.42 EUR per share. See more details about Novavax, Inc. earnings.
Novavax, Inc. revenue for the last quarter amounts to 60.03 M EUR, despite the estimated figure of 35.90 M EUR. In the next quarter, revenue is expected to reach 78.24 M EUR.
NVAX net income for the last quarter is −172.47 M EUR, while the quarter before that showed 90.42 M EUR of net income which accounts for −290.75% change. Track more Novavax, Inc. financial stats to get the full picture.
No, NVAX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 20, 2025, the company has 952 employees. See our rating of the largest employees — is Novavax, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Novavax, Inc. EBITDA is 384.97 M EUR, and current EBITDA margin is −26.90%. See more stats in Novavax, Inc. financial statements.
Like other stocks, NVAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Novavax, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Novavax, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Novavax, Inc. stock shows the strong sell signal. See more of Novavax, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.













